Base-Labile RNA Synthesis Protecting Groups

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The synthesis of RNA is complex due to the instability of RNA in basic media and the difficulty in finding suitable protecting groups for the hydroxyl function in position 2′ of the ribose sugar, leading to low yields and contamination with fluoride salts in existing RNA synthesis methods.

Innovation Solution

A method using a base-labile protecting group for the hydroxyls in position 2′ of the ribose, such as pivaloyloxymethyl or acetyloxymethyl groups, which can be removed in basic conditions without nucleophilic attack or rupture of the 3′-5′ linkers, allowing for a fully base-labile RNA synthesis strategy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If base-labile protecting groups are used for phosphate protection in RNA synthesis, then deprotection can be achieved by single base treatment, but the hydroxyl group at position 2' of ribose becomes unstable and undergoes nucleophilic attack leading to 2'-5' isomerization or linker rupture

Engineering Contradiction:
ImproveDeprotection process simplicityVSAvoidRNA structural stability
Core Design Contradiction:
Ease of manufactureVSReliability

Solution Approach 1:

The patent segments the deprotection process into two distinct stages: first removing the phosphate protecting group (X2) under mild basic conditions, then removing the 2'-O protecting group (X3) under stronger basic conditions. This segmentation allows each deprotection step to be optimized independently, preventing nucleophilic attack on the 2'-hydroxyl during the first stage while still achieving complete deprotection ultimately.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent applies preliminary action by removing the phosphate protecting group before removing the 2'-O protecting group. This sequence prevents the 2'-hydroxyl from being exposed to basic conditions when the phosphate is still protected, thereby preventing nucleophilic attack and 2'-5' isomerization. The 2'-O deprotection is performed only after the phosphate protection is already removed, making the system more stable during the critical deprotection phase.

Inventive Principle:
Principle #10Preliminary action

2Ease of manufacture

If fluoride ion is used to remove silyl protecting groups from ribose 2'-OH, then the protecting group can be removed effectively, but the RNA product becomes contaminated with fluoride salts requiring additional purification steps

Engineering Contradiction:
ImproveProtecting group removal efficiencyVSAvoidFluoride salt contamination
Core Design Contradiction:
Ease of manufactureVSObject-generated harmful factors

Solution Approach 1:

The patent changes the chemical parameter of the deprotection reagent from fluoride ions to hydroxide ions (basic conditions). This parameter change allows the 2'-O protecting group to be removed without introducing fluoride salt contamination. The base-labile 2'-O protecting groups are cleaved by hydroxide ions through a different mechanism that does not generate harmful fluoride byproducts, thereby simplifying purification.

Inventive Principle:
Principle #35Parameter changes

3Device complexity

If standard DNA synthesis strategy with base-labile protecting groups is applied to RNA synthesis, then the synthesis protocol can be simplified, but the RNA undergoes 2'-5' isomerization or linker rupture due to nucleophilic attack by 2'-OH

Engineering Contradiction:
ImproveSynthesis protocol complexityVSAvoidRNA structural integrity
Core Design Contradiction:
Device complexityVSManufacturing precision

Solution Approach 1:

The patent segments the protecting groups into two categories with different deprotection conditions: phosphate protecting groups (X2) that are removed under mild basic conditions, and 2'-O protecting groups (X3) that require stronger basic conditions for removal. This segmentation allows the synthesis protocol to remain relatively simple while preventing 2'-5' isomerization, as the 2'-OH is not exposed to base until the phosphate protection is already removed.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent changes the stability parameter of the 2'-O protecting group by selecting base-labile groups (such as acyloxymethyl or acylthiomethyl groups) that are stable under mild basic conditions but removable under stronger basic conditions. This parameter change allows the protecting group to survive the phosphate deprotection step while still being removable later, thereby maintaining both protocol simplicity and RNA structural integrity.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the efficient synthesis of RNA with improved purity and reduced contamination, allowing for the production of high-quality RNA without the need for additional purification steps and enhances the RNA's permeability and resistance to nucleases.

Implementation Method 1

A method using a base-labile protecting group for the hydroxyls in position 2′ of the ribose, such as pivaloyloxymethyl or acetyloxymethyl groups, which can be removed in basic conditions without nucleophilic attack or rupture of the 3′-5′ linkers

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Data Source

PatentUS8536318B2Chemical RNA synthesis method
Publication Date: 2013.09.17 CHEMGENES CORP
  • US8536318B2 patent drawing
  • US8536318B2 patent drawing
  • US8536318B2 patent drawing

AI summary

The invention relates to a method for the chemical synthesis of RNA, comprising the following steps: a) bonding to a solid support of a monomer having formula (II) in which—X1 is a dimethoxytrityl group,—X6 is H or an OAc group or OX3, in which X3 is a group having formula (A), in which X is O or S, R′ is H or CH3 and R is selected from a linear or branched alkyl group at C1 to C4 and a R1—O—R2 group in which R1 is an alkyl group at C1 to C2 and R2 is a CH3 group or CH2CH2—O—CH3 or aryl; b) assembly with the monomer having formula (II) bound to the support thereof obtained in step (a) of at least one monomer having formula (III) in which X1, Bp, X3 are as defined for formula (II) and X5 is a hydrogen phosphonate monoester or phosphoramidite group, preferably a 2-cyanoethyl-N,N-diisopropylphosphoramidite group, which is used to obtain a protected single-strand RNA bound to a support.